Skip to content

Prospective cohort study on the new model of the whole process health management of pregnant diabetes patients in the era of Big data

Prospective cohort study on the new model of the whole process health management of pregnant diabetes patients in the era of Big data

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073404
Enrollment
Unknown
Registered
2023-07-10
Start date
2023-07-10
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes

Interventions

study group:The research group provided continuous care based on information technology on the basis of the control group
control group:The control group received routine nursing intervention

Sponsors

Hunan provincial maternal and child health care hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 42 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) All pregnant women conformed to the standard of diagnosis and treatment for GDM6. The diagnosis was confirmed by oral glucose tolerance test (Oral glucose was purchased from Shanghai Yanjin Biotechnology Co., Ltd., No. 9138 Beiqing Road, Qingpu District, Shanghai, China; product number: Js11050-25 g; brand YOYOBIO); (2) The fasting blood glucose (FBG) of pregnant women exceeded 7.0 mmol/L, and the blood glucose exceeded 11.0 mmol/L one hour after taking sugar; (3) The maternal age was over 20 years old; (4) Pregnant women and their families had informed consent and signed the informed consent; (5) Medical records were complete. Participants could cooperate with treatment and could use the Wechat or telephone to finish the post hospital follow-up after discharge.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) Pregnant woman who had symptoms of diabetes, such as polydipsia, polydipsia, polyuria or weight loss before pregnancy or these who had made a definite diagnosis as diabetes. (2) Pregnant woman who took antibiotics and other drugs or sugary foods before participating in the study; (3) Pregnant woman who had inflammatory diseases such as inflammatory bowel disease, hypertension and autoimmune diseases. (4) Pregnant woman with severe insufficiency of heart function or liver and kidney function; (5) Pregnant woman was accompanied by mental illness and was unable to cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose,FBG;2h postprandial glucose,2hPG;

Countries

China

Contacts

Public ContactZeng Xiu

Hunan provincial maternal and child health care hospital

shihuimedical@126.com+86 731 8433 2201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026